BeOne Medicines Ltd. (NASDAQ:ONC) is a top high-growth international stock to buy now, with Citizens JMP analyst setting a price target of $348. On August 29, positive results for Sonrotoclax in Mantle Cell Lymphoma were announced. The company plans to submit data for regulatory review. BeOne Medicines focuses on affordable cancer treatments globally.

Read more at Yahoo Finance: Citizens JMP Maintains a Buy Rating on BeOne Medicines (ONC)